Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

NANOPARTICLE TROJAN HORSE MOLECULAR DELIVERY SYSTEM

10/9/2008

- Interview with Dr. Ian Larson, Senior Lecturer in Pharmaceutics and Formulation Science, Monash University

Scientists from Monash University have designed a nano-sized "Trojan horse" particle to ensure that healing antioxidants and therapeutic drugs can be better absorbed by the human body. The nanoparticle, one thousandth the thickness of a human hair, protects antioxidants from being destroyed in the gut and ensures a better chance of them being taken up in the digestive tract.


During this week's podcast, Dr. Ian Larson provides additional details on how the nanoparticle his research team developed actually functions. Dr. Larson talks about the broad practical applications of nanoparticle technology in the food industry and how other types of molecules or drugs might be administered via the nano particle delivery route. Dr. Larson also describes his work on drug delivery systems involving inhalation medication as well as liquid crystalline injections.
Dr.Ian Larson is a Senior Lecturer in Pharmaceutics and Formulation Science at Monash University in Australia.

Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll